| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $1.42B | -12.1% |
| Cost of Revenue | $873.9M | -11.8% |
| Gross Profit | $544.6M | -12.6% |
| R&D Expense | $300.4M | -5.2% |
| SG&A Expense | $132.7M | +6.3% |
| Operating Income | -$83.7M | -1628.3% |
| Pre-tax Income | -$133.0M | -664.2% |
| Income Tax | $17.3M | +121.8% |
| Net Income | -$150.3M | -496.3% |
| EPS (Basic) | -$0.64 | -481.8% |
| EPS (Diluted) | -$0.64 | -481.8% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.8M | -15.5% |
| Accounts Receivable | $336.6M | -11.9% |
| Inventory | $308.2M | -28.5% |
| Current Assets | $945.8M | -15.2% |
| Total Assets | $1.53B | -8.7% |
| Current Liabilities | $626.8M | -7.0% |
| Long-term Debt | $667.9M | +1.4% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.7M | +63.0% |
| Capital Expenditures | $75.0M | +20.4% |
| Investing Cash Flow | -$75.0M | -20.4% |
| Financing Cash Flow | -$32.2M | -335.0% |
| Free Cash Flow | $5.7M | +144.3% |
| Stockholders' Equity |
| $116.5M |
| -46.2% |